Results 41 to 50 of about 2,602,735 (305)

Risk of Intracranial Hemorrhage Associated With Direct Oral Anticoagulation vs Antiplatelet Therapy

JAMA Network Open
Key Points Question Is there a significant difference in risk of intracranial hemorrhage (ICH) among patients taking direct oral anticoagulation (DOAC) compared with antiplatelet therapy?
Mark Coyle, Amy Lynch, Meave Higgins, Maria Costello, C. Judge, Martin O’Donnell, C. Reddin   +6 more
semanticscholar   +1 more source

Oral Anticoagulation in Asian Patients With Atrial Fibrillation and a History of Intracranial Hemorrhage

Stroke, 2019
Supplemental Digital Content is available in the text. Background and Purpose— Warfarin is associated with a better net clinical benefit compared with no treatment in patients with nonvalvular atrial fibrillation (AF) and history of intracranial ...
So-Ryoung Lee, E. Choi, S. Kwon, Jin-Hyung Jung, Kyungdo Han, M. Cha, Seil Oh, G. Lip   +7 more
semanticscholar   +1 more source

Risk Factors of Post-Tonsillectomy Bleeding and Differences Between Children and Adults: Implications for Risk Assessment

Turkish Archives of Otorhinolaryngology
Objective: To investigate the association between clinical factors and post-tonsillectomy hemorrhage (PTH) including rebleeding episodes. Methods: The medical records of 1,082 patients who underwent tonsillectomy between May 2018 and April 2019 were ...
Bülent Öcal, Mehmet Murat Günay, Kemal Keseroğlu, Murad Mutlu, İlker Akyıldız, Cem Saka, Emel Çadallı Tatar, Mehmet Hakan Korkmaz   +7 more
doaj   +1 more source

Reversal of oral anticoagulation in patients with acute intracerebral hemorrhage

Critical Care, 2019
In light of an aging population with increased cardiovascular comorbidity, the use of oral anticoagulation (OAC) is steadily expanding. A variety of pharmacological alternatives to vitamin K antagonists (VKA) have emerged over recent years (direct oral ...
J. Kuramatsu, J. Sembill, H. Huttner
semanticscholar   +1 more source

Effects of Dabigatran in Mouse Models of Aging and Cerebral Amyloid Angiopathy

Frontiers in Neurology, 2019
Oral anticoagulants are a critical component of stroke prevention, but carry a risk of brain hemorrhage. These hemorrhagic complications tend to occur in elderly individuals, especially those with predisposing conditions such as cerebral amyloid ...
Neethu Michael, Mher Mahoney Grigoryan, Kelley Kilday, Rachita K. Sumbria, Rachita K. Sumbria, Vitaly Vasilevko, Joanne van Ryn, David H. Cribbs, Annlia Paganini-Hill, Mark J. Fisher, Mark J. Fisher, Mark J. Fisher   +11 more
doaj   +1 more source

Case Report: Intraocular Hemorrhage in a Primary Vitreoretinal Lymphoma Patient Treated With Zanubrutinib

Frontiers in Medicine, 2022
PurposeTo report a case of primary vitreoretinal lymphoma (PVRL) treated with oral zanubrutinib, who had bilateral intraocular hemorrhage after intravitreal injection of methotrexate (MTX).Case reportA 69-year-old Chinese female presented with vision ...
Xiao Zhang, Xiao Zhang, Rongping Dai, Rongping Dai, Chan Zhao, Chan Zhao, Meifen Zhang, Meifen Zhang   +7 more
doaj   +1 more source

Recurrent Vitreous Hemorrhage from an Optic Nerve Retinal Arterial Macroaneurysm

Case Reports in Ophthalmology, 2017
Objective: To report a case of recurrent vitreous hemorrhage from an optic nerve retinal arterial macroaneurysm (ONRAM) successfully treated with intraoperative endolaser.
Jessica F. Yang, Kamal Kishore
doaj   +1 more source

Characteristics in Non-Vitamin K Antagonist Oral Anticoagulant-Related Intracerebral Hemorrhage.

Stroke, 2019
Background and Purpose- Given inconclusive studies, it is debated whether clinical and imaging characteristics, as well as functional outcome, differ among patients with intracerebral hemorrhage (ICH) related to vitamin K antagonists (VKA) versus non ...
S. Gerner, J. Kuramatsu, J. Sembill, M. Sprügel, Manuel Hagen, R. Knappe, M. Endres, K. Haeusler, J. Sobesky, J. Schurig, S. Zweynert, Miriam Bauer, P. Vajkoczy, P. Ringleb, J. Purrucker, T. Rizos, J. Volkmann, W. Müllges, P. Kraft, Anna-Lena Schubert, F. Erbguth, Martin Nueckel, P. Schellinger, J. Glahn, U. Knappe, G. Fink, C. Dohmen, H. Stetefeld, A. Fisse, J. Minnerup, G. Hagemann, F. Rakers, H. Reichmann, H. Schneider, J. Rahmig, A. Ludolph, Sebastian Stösser, H. Neugebauer, J. Röther, P. Michels, Michael Schwarz, G. Reimann, H. Bäzner, Henning Schwert, J. Classen, D. Michalski, A. Grau, F. Palm, Christian Urbanek, J. Wöhrle, Fahid Alshammari, M. Horn, D. Bahner, O. Witte, A. Günther, G. Hamann, T. Engelhorn, H. Lücking, A. Dörfler, S. Schwab, H. Huttner   +60 more
semanticscholar   +1 more source

Oral Anticoagulant and Antiplatelet Therapy for Peripheral Arterial Disease: A Meta-analysis of Randomized Controlled Trials

Clinical and Applied Thrombosis/Hemostasis, 2021
Peripheral artery disease (PAD) is a common disease affecting over 200 million people worldwide. PAD is associated with significant limb and cardiovascular morbidity and mortality which is reduced by antiplatelet and antithrombotic therapy.
Tao Tang PhD, Ming Zhang PhD, Wendong Li PhD, Nan Hu PhD, Xiaolong Du PhD, Feng Ran PhD, Xiaoqiang Li PhD   +6 more
doaj   +1 more source

Non–Vitamin K Antagonist Oral Anticoagulants Versus Warfarin in Atrial Fibrillation Patients With Intracerebral Hemorrhage

Stroke, 2019
Background and Purpose— Recurrent bleeding associated with oral anticoagulants (OACs) causes a dilemma in patients with atrial fibrillation (AF) sustaining an intracerebral hemorrhage.
P. Nielsen, F. Skjøth, M. Søgaard, J. N. Kjældgaard, G. Lip, T. Larsen   +5 more
semanticscholar   +1 more source